Resultados de la búsqueda 281-290 de 3078 para anti-TNF drugs

  1. Inhibidores selectivos de la recaptación de serotonina (ISRS) - Mayo Clinic

    https://www.fda.gov/drugs/information-drug-class/selective-serotonin-reuptake-inhibitors-ssris-information. Accessed Aug. 19, 2019. Hirsch M, et al. Selective ...

  2. Terapia hormonal para el cáncer de próstata - Mayo Clinic

    Hormone therapy for prostate cancer. National Cancer Institute. https://www.cancer.gov/types/prostate/prostate-hormone-therapy-fact-sheet. Accessed Feb. 16 ...

  3. Alergias a los medicamentos - Síntomas y causas - Mayo Clinic

    Drug allergy. In: Goldman-Cecil Medicine. 26th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Oct. 2, 2020. Pichler WJ. Drug hypersensitivity ...

  4. Niacina - Mayo Clinic

    La niacina de venta bajo receta podría beneficiar a las personas con colesterol alto que no pueden tomar estatinas o que no han logrado controlar sus niveles de ...

  5. Drogadicción (trastorno de consumo de sustancias) - Diagnóstico y tratamiento - Mayo Clinic

    Accessed Aug. 17, 2022. Principles of drug addiction treatment: A research-based guide. 3rd ed. National Institute on Drug Abuse. https://www.drugabuse.gov/ ...

  6. Medicamentos con receta para adelgazar: ¿pueden ayudarte? - Mayo Clinic

    AskMayoExpert. Obesity (adult). Mayo Clinic; 2018. Pilitsi E, et al. Pharmacotherapy of obesity: Available medications and drugs under investigation. Metabolism ...

  7. Gastroenterología y Hepatología - Ensayos clínicos

    ... therapy selection tool for systemic therapy in CRC peritoneal disease. ... Prior to an operation, UC is treated with antibiotic therapy, immunomodulatory therapy ...

  8. Radiología - Ensayos clínicos - Mayo Clinic

    ... treatment. A Study to Determine the Tradeoffs between CT Image Quality and Patient Radiation Dose. Rochester, Minn. The purpose of this study is to determine ...

  9. Oncología radioterápica - Ensayos clínicos

    Jacksonville, Fla. The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, ...

  10. Nefrología e hipertensión - Ensayos clínicos

    ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.